UVA Cancer Center

University of Virginia Health System

Charlottesville, VA

Sorting 3 by

Not currently accepting

EQUATE

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Learn more
  • Monoclonal Antibody
  • CD38
  • Phase 3

Accepting patients

DURGA-2

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma
Learn more
  • CAR T Cell
  • CD19
  • BCMA
  • High Risk
  • Phase 1

Accepting patients

DURGA-1

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Learn more
  • CAR T Cell
  • CD19
  • BCMA
  • Phase 1/2
  • Has results
1 hidden based on your filters.Show All